Go to:
Logótipo
You are here: Start > Publications > View > 2-Styrylchromones Prevent IL-1 beta-Induced Pro-Inflammatory Activation of Fibroblast-like Synoviocytes while Increasing COX-2 Expression
Bandeira a meia haste - A FEUP encontra-se de luto
Concurso de Escrita Criativa da FEUP
Publication

2-Styrylchromones Prevent IL-1 beta-Induced Pro-Inflammatory Activation of Fibroblast-like Synoviocytes while Increasing COX-2 Expression

Title
2-Styrylchromones Prevent IL-1 beta-Induced Pro-Inflammatory Activation of Fibroblast-like Synoviocytes while Increasing COX-2 Expression
Type
Article in International Scientific Journal
Year
2023
Authors
Rufino, AT
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lucas, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Silva, AMS
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ribeiro, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Eduarda Fernandes
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Title: PharmaceuticsImported from Authenticus Search for Journal Publications
Vol. 15
Final page: 780
ISSN: 1999-4923
Publisher: MDPI
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge - 0 Citations
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-00Y-7BW
Abstract (EN): Rheumatoid arthritis (RA) is characterized by systemic immune and chronic inflammatory features, leading to the destruction of the joints. Presently, there are no effective drugs able to control synovitis and catabolism in the process of RA. 2-Styrylchromones (2-SC) are a small group of compounds characterized by the attachment of a styryl group to the chromone core that have already been associated to a wide range of biological activities, including antioxidant and anti-inflammatory activities. The present study investigated the effect of a set of six 2-SC on the interleukin-1 beta (IL-1 beta)-induced increase of nitric oxide ((NO)-N-center dot), inducible form of nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and matrix metalloproteinase-3 (MMP-3) expression levels in human fibroblast-like synoviocytes (HFLS), pointing to the role of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) activation in the process. From a set of six 2-SC, presenting hydroxy and methoxy substituents, the one presenting two methoxy substituents at C-5 and C-7 of A ring and a catechol group on B ring, significantly reduced (NO)-N-center dot production and the expression of its inducible synthase (iNOS). It also significantly reduced the catabolic MMP-3 protein expression. This 2-SC inhibited the NF-kappa B pathway by reversing the IL-1 beta - induced levels of cytoplasmatic NF-kB inhibitor alpha (I kappa B alpha), and decreasing the p65 nuclear levels, suggesting the involvement of these pathways in the observed effects. The same 2-SC significantly increased the COX-2 expression, which may indicate a negative feedback loop mechanism of action. The properties of 2-SC may be of great value in the development of new therapies with improved efficacy and selectivity towards RA, and thus deserve further exploitation and evaluation to disclose the full potential of 2-SC.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 13
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Second-Generation Antimitotics in Cancer Clinical Trials (2021)
Another Publication in an International Scientific Journal
Novais, P; Silva, PMA; Maria Isabel Amorim; Bousbaa, H
Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies (2020)
Another Publication in an International Scientific Journal
Teixeira, MI; Maria Helena Amaral; Paulo Costa; Lopes, CM; Lamprou, DA
Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence (2020)
Another Publication in an International Scientific Journal
Menditto, E; Orlando, V; De Rosa, G; Minghetti, P; Musazzi, UM; Cahir, C; Kurczewska Michalak, M; Kardas, P; Costa, E; Sousa Lobo JM; Almeida, IF
Nanopharmaceutics: Part I-Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU (2020)
Another Publication in an International Scientific Journal
Souto, EB; Silva, GF; Dias Ferreira, J; Zielinska, A; Ventura, F; Durazzo, A; Lucarini, M; Novellino, E; Santini, A
Magnetic Bone Tissue Engineering: Reviewing the Effects of Magnetic Stimulation on Bone Regeneration and Angiogenesis (2023)
Another Publication in an International Scientific Journal
Ribeiro, TP; Flores, M; Madureira, S; Zanotto, F; Fernando Mendes Monteiro; Laranjeira, MS

See all (93)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2024-09-26 at 22:47:49 | Acceptable Use Policy | Data Protection Policy | Complaint Portal